Inborn errors of metabolism
MONDO:0019052An inherited disorder resulting from an enzyme defect in biochemical and metabolic pathways affecting proteins, fats, carbohydrates metabolism or organelle function.
Also known as: congenital metabolic disorder, congenital metabolism disorder, hereditary metabolic disease, inborn disorders of metabolism, inborn error of metabolism, inborn errors of metabolism, inborn metabolic disorder, inherited disorder of metabolism
2228 clinical trials for this condition and its sub-types, 48 tagged with Inborn errors of metabolism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inborn errors of metabolism
-
Inherited lipid metabolism disorder 201 trials · 644 incl. sub-types
29 sub-types
- Lysosomal lipid storage disorder 2 trials · 192 incl. sub-types Sub-types →
- Familial hyperlipidemia 8 trials · 130 incl. sub-types Sub-types →
- Syndromic dyslipidemia 0 trials · 73 incl. sub-types Sub-types →
- Sterol metabolism disorder 0 trials · 60 incl. sub-types Sub-types →
- Steroid inherited metabolic disorder 0 trials · 39 incl. sub-types Sub-types →
- Inherited fatty acid metabolism disorder 7 trials · 21 incl. sub-types Sub-types →
- Disorder of phospholipids, sphingolipids and fatty acids biosynthesis 0 trials · 15 incl. sub-types Sub-types →
- Hypolipoproteinemia 2 trials · 7 incl. sub-types Sub-types →
- Glucocorticoid resistance 3 trials
- Mitochondrial trifunctional protein deficiency 3 trials Sub-types →
- Vitamin D hydroxylation-deficient rickets, type 1B 3 trials
- 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency 2 trials
- CYP7B1-related disorder of oxysterol accumulation 0 trials · 2 incl. sub-types Sub-types →
- Disorder of plasmalogens biosynthesis 0 trials · 2 incl. sub-types Sub-types →
- Disorder of sphingolipid biosynthesis 1 trial
- Inborn disorder of ketolysis 0 trials · 1 incl. sub-types Sub-types →
- Corticosterone methyloxidase type 1 deficiency 0 trials
- Cortisone reductase deficiency 0 trials Sub-types →
- Developmental and epileptic encephalopathy, 55 0 trials
- Developmental and epileptic encephalopathy, 77 0 trials
- Developmental and epileptic encephalopathy, 80 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 15 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 16 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 17 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 18 0 trials
- Inborn disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation 0 trials Sub-types →
- Lipoid proteinosis 0 trials
- Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures 0 trials
- Pancreatic triacylglycerol lipase deficiency 0 trials Sub-types →
-
Inborn carbohydrate metabolic disorder 3 trials · 369 incl. sub-types
18 sub-types
- Disorder of carbohydrate transmembrane transport and absorption 0 trials · 162 incl. sub-types Sub-types →
- Disorder of glycogen metabolism 15 trials · 69 incl. sub-types Sub-types →
- Mucopolysaccharidosis 14 trials · 61 incl. sub-types Sub-types →
- Disorder of glycolysis 1 trial · 27 incl. sub-types Sub-types →
- Primary hyperoxaluria 13 trials · 17 incl. sub-types Sub-types →
- Hyperinsulinemic hypoglycemia 2 trials · 14 incl. sub-types Sub-types →
- Oligosaccharidosis 0 trials · 11 incl. sub-types Sub-types →
- Lactose intolerance 9 trials · 10 incl. sub-types Sub-types →
- G6PD deficiency 6 trials Sub-types →
- GLUT1 deficiency syndrome 4 trials · 5 incl. sub-types Sub-types →
- Disorder of galactose metabolism 0 trials · 5 incl. sub-types Sub-types →
- Disorder of galactose and fructose metabolism 0 trials · 4 incl. sub-types Sub-types →
- Pyruvate dehydrogenase deficiency 2 trials · 4 incl. sub-types Sub-types →
- Multiple carboxylase deficiency 0 trials · 3 incl. sub-types Sub-types →
- Congenital disorder of deglycosylation 1 2 trials
- Disorder of fructose metabolism 0 trials · 1 incl. sub-types Sub-types →
- Disorder of gluconeogenesis 0 trials · 1 incl. sub-types Sub-types →
- Disorders of pentose/polyol metabolism 0 trials · 1 incl. sub-types Sub-types →
-
Abdominal obesity-metabolic syndrome 301 trials · 357 incl. sub-types
5 sub-types
- Metabolic syndrome X 338 trials
- LIPE-related familial partial lipodystrophy 0 trials
- Abdominal obesity-metabolic syndrome 3 0 trials
- Abdominal obesity-metabolic syndrome 4 0 trials
- Abdominal obesity-metabolic syndrome quantitative trait locus 2 0 trials
-
Lysosomal storage disease 37 trials · 302 incl. sub-types
11 sub-types
- Lysosomal lipid storage disorder 2 trials · 192 incl. sub-types Sub-types →
- Mucopolysaccharidosis 14 trials · 61 incl. sub-types Sub-types →
- Lysosomal glycogen storage disease 0 trials · 45 incl. sub-types Sub-types →
- Inborn disorder of lysosomal amino acid transport 0 trials · 15 incl. sub-types Sub-types →
- Glycoproteinosis 0 trials · 14 incl. sub-types Sub-types →
- Late infantile neuronal ceroid lipofuscinosis 1 trial · 5 incl. sub-types Sub-types →
- Disorder of sialic acid metabolism 0 trials · 1 incl. sub-types Sub-types →
- Glycoprotein storage disease 0 trials
- Hereditary spastic paraplegia 48 0 trials
- Lysosomal acid phosphatase deficiency 0 trials
- Pycnodysostosis 0 trials
-
Inborn disorder of energy metabolism 2 trials · 235 incl. sub-types
6 sub-types
- Inborn mitochondrial metabolism disorder 59 trials · 127 incl. sub-types Sub-types →
- Disorder of glycogen metabolism 15 trials · 69 incl. sub-types Sub-types →
- Pyruvate metabolism disorder 0 trials · 31 incl. sub-types Sub-types →
- Disorder of fatty acid and ketone body metabolism 3 trials · 19 incl. sub-types Sub-types →
- Cerebral creatine deficiency syndrome 0 trials · 6 incl. sub-types Sub-types →
- Tricarboxylic acid cycle disorder 0 trials · 2 incl. sub-types Sub-types →
-
Inborn disorder of amino acid and other organic acid metabolism 0 trials · 225 incl. sub-types
13 sub-types
- Inborn disorder of amino acid metabolism 6 trials · 159 incl. sub-types Sub-types →
- Pyruvate metabolism disorder 0 trials · 31 incl. sub-types Sub-types →
- Inherited fatty acid metabolism disorder 7 trials · 21 incl. sub-types Sub-types →
- Disorder of melanin metabolism 0 trials · 15 incl. sub-types Sub-types →
- Inborn disorder of bile acid synthesis 2 trials · 12 incl. sub-types Sub-types →
- Inborn disorder of methionine cycle and sulfur amino acid metabolism 0 trials · 11 incl. sub-types Sub-types →
- Inborn disorder of ornithine or proline metabolism 0 trials · 4 incl. sub-types Sub-types →
- Inborn error of biotin metabolism 0 trials · 3 incl. sub-types Sub-types →
- Inborn disorder of serine family metabolism 0 trials · 1 incl. sub-types Sub-types →
- Inborn disorder of the gamma-glutamyl cycle 0 trials · 1 incl. sub-types Sub-types →
- Disorder of beta and omega amino acid metabolism 0 trials Sub-types →
- Disorder of glutamine metabolism 0 trials Sub-types →
- Inborn disorder of lysine and hydroxylysine metabolism 0 trials Sub-types →
-
Waldenstrom macroglobulinemia 136 trials
2 sub-types
- Macroglobulinemia, Waldenstrom, 1 2 trials
- Macroglobulinemia, Waldenstrom, 2 0 trials
-
DNA repair disease 13 trials · 105 incl. sub-types
16 sub-types
- Fanconi anemia 29 trials · 42 incl. sub-types Sub-types →
- Mismatch repair cancer syndrome 5 trials · 36 incl. sub-types Sub-types →
- Cockayne syndrome 6 trials Sub-types →
- Xeroderma pigmentosum 4 trials · 6 incl. sub-types Sub-types →
- Severe combined immunodeficiency due to DCLRE1C deficiency 3 trials
- Karyomegalic interstitial nephritis 2 trials
- Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 0 trials · 2 incl. sub-types Sub-types →
- COFS syndrome 1 trial Sub-types →
- Nijmegen breakage syndrome 1 trial
- Nijmegen breakage syndrome-like disorder 0 trials
- UV-sensitive syndrome 0 trials Sub-types →
- Ataxia and polyneuropathy, adult-onset 0 trials
- Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia 0 trials
- Ataxia-telangiectasia-like disorder 1 0 trials
- Ataxia-telangiectasia-like disorder 2 0 trials
- Photosensitive trichothiodystrophy 0 trials Sub-types →
-
Hereditary amyloidosis 19 trials · 79 incl. sub-types
9 sub-types
- Familial amyloid neuropathy 52 trials · 54 incl. sub-types Sub-types →
- Cerebral amyloid angiopathy 16 trials · 17 incl. sub-types Sub-types →
- APP-related brain and vascular amyloidosis 0 trials · 5 incl. sub-types Sub-types →
- Familial primary localized cutaneous amyloidosis 1 trial Sub-types →
- Finnish type amyloidosis 0 trials
- ITM2B amyloidosis 0 trials Sub-types →
- Familial visceral amyloidosis 0 trials Sub-types →
- Pulmonary amyloidosis 0 trials
- Variant ABeta2M amyloidosis 0 trials
-
Inborn disorder of porphyrin metabolism 0 trials · 63 incl. sub-types
4 sub-types
- Inborn disorder of bilirubin metabolism 0 trials · 39 incl. sub-types Sub-types →
- Inherited porphyria 0 trials · 24 incl. sub-types Sub-types →
- X-linked sideroblastic anemia 1 0 trials
- Heme oxygenase 1 deficiency 0 trials
-
Mucopolysaccharidosis or mucopolysaccharidosis-like disorder 0 trials · 61 incl. sub-types
2 sub-types
- Mucopolysaccharidosis 14 trials · 61 incl. sub-types Sub-types →
- Mucopolysaccharidosis-plus syndrome 0 trials
-
Inborn metal metabolism disorder 1 trial · 60 incl. sub-types
9 sub-types
- Wilson disease 31 trials
- Pseudohypoparathyroidism 8 trials · 9 incl. sub-types Sub-types →
- Hereditary hemochromatosis 8 trials Sub-types →
- Menkes disease 5 trials
- Familial primary hypomagnesemia 5 trials Sub-types →
- Acrodermatitis enteropathica 2 trials
- Atransferrinemia 1 trial
- Familial periodic paralysis 0 trials · 1 incl. sub-types Sub-types →
- Sulfite oxidase deficiency due to molybdenum cofactor deficiency 0 trials · 1 incl. sub-types Sub-types →
-
Disorder of metabolite absorption and transport 0 trials · 59 incl. sub-types
3 sub-types
- Disorder of mineral absorption and transport 0 trials · 50 incl. sub-types Sub-types →
- Disorder of vitamin and non-protein cofactor absorption and transport 0 trials · 10 incl. sub-types Sub-types →
- Maternal riboflavin deficiency 0 trials
-
Inborn disorder of purine or pyrimidine metabolism 1 trial · 50 incl. sub-types
4 sub-types
- Disorder of glycolysis 1 trial · 27 incl. sub-types Sub-types →
- Inborn disorder of purine metabolism 0 trials · 14 incl. sub-types Sub-types →
- Inborn disorder of pyrimidine metabolism 0 trials · 11 incl. sub-types Sub-types →
- Phosphoribosylpyrophosphate synthetase deficiency 0 trials
-
Plasma protein metabolism disease 0 trials · 47 incl. sub-types
3 sub-types
- Alpha 1-antitrypsin deficiency 44 trials
- Monoclonal paraproteinemia disease 2 trials
- Polyclonal hypergammaglobulinemia 1 trial
-
Peroxisomal disease 2 trials · 38 incl. sub-types
4 sub-types
- Peroxisomal single enzyme/protein defect 0 trials · 35 incl. sub-types Sub-types →
- Peroxisome biogenesis disorder 4 trials · 8 incl. sub-types Sub-types →
- CADDS 0 trials
- Disorder of defective peroxisomal and mitochondrial fission 0 trials Sub-types →
-
Congenital disorder of glycosylation 7 trials · 36 incl. sub-types
25 sub-types
- Disorder of protein O-glycosylation 0 trials · 13 incl. sub-types Sub-types →
- Disorder of multiple glycosylation 0 trials · 9 incl. sub-types Sub-types →
- Congenital disorder of glycosylation type I 0 trials · 7 incl. sub-types Sub-types →
- Disorder of protein N-glycosylation 0 trials · 7 incl. sub-types Sub-types →
- Congenital disorder of glycosylation type II 0 trials · 3 incl. sub-types Sub-types →
- Autosomal recessive limb-girdle muscular dystrophy type 2P 1 trial
- A4GALT-congenital disorder of glycosylation 0 trials
- ALG10-congenital disorder of glycosylation 0 trials
- ALG14-congenital disorder of glycosylation 0 trials Sub-types →
- B3GALT6-congenital disorder of glycosylation 0 trials Sub-types →
- Ehlers-Danlos syndrome, musculocontractural type 0 trials Sub-types →
- FAM20B-congenital disorder of glycosylation 0 trials
- Larsen-like syndrome, B3GAT3 type 0 trials
- SLC10A7-congenital disorder of glycosylation 0 trials
- XYLT1-congenital disorder of glycosylation 0 trials
- Congenital disorder of glycosylation syndrome type 4 0 trials
- Congenital disorder of glycosylation with defective fucosylation 0 trials Sub-types →
- Congenital disorder of glycosylation, type 1DD 0 trials
- Congenital disorder of glycosylation, type Ibb 0 trials
- Congenital disorder of glycosylation, type Iw, autosomal dominant 0 trials
- Congenital muscular dystrophy with intellectual disability 0 trials
- Inborn disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation 0 trials Sub-types →
- Progressive myoclonic epilepsy type 3 0 trials
- Seizures-scoliosis-macrocephaly syndrome 0 trials
- Temtamy preaxial brachydactyly syndrome 0 trials
-
Monogenic diabetes 9 trials · 24 incl. sub-types
2 sub-types
- Maturity-onset diabetes of the young 8 trials · 13 incl. sub-types Sub-types →
- Neonatal diabetes mellitus 3 trials · 6 incl. sub-types Sub-types →
-
Glycoprotein metabolism disease 1 trial · 23 incl. sub-types
3 sub-types
- Disorder of protein O-glycosylation 0 trials · 13 incl. sub-types Sub-types →
- Disorder of protein N-glycosylation 0 trials · 7 incl. sub-types Sub-types →
- Congenital disorder of deglycosylation 1 2 trials
-
Hereditary lipodystrophy 2 trials · 17 incl. sub-types
11 sub-types
- Familial partial lipodystrophy 13 trials · 14 incl. sub-types Sub-types →
- Congenital generalized lipodystrophy 2 trials · 3 incl. sub-types Sub-types →
- Berardinelli-Seip congenital lipodystrophy 0 trials · 1 incl. sub-types Sub-types →
- Keppen-Lubinsky syndrome 0 trials
- SHORT syndrome 0 trials
- Wiedemann-Rautenstrauch syndrome 0 trials
- Lipoatrophy with diabetes, leukomelanodermic papules, liver steatosis, and hypertrophic cardiomyopathy 0 trials
- Lipodystrophy due to peptidic growth factors deficiency 0 trials
- Lipodystrophy-intellectual disability-deafness syndrome 0 trials
- Mandibuloacral dysplasia 0 trials Sub-types →
- Severe neurodegenerative syndrome with lipodystrophy 0 trials
-
Familial intrahepatic cholestasis 1 trial · 17 incl. sub-types
4 sub-types
- Progressive familial intrahepatic cholestasis 16 trials · 17 incl. sub-types Sub-types →
- Benign recurrent intrahepatic cholestasis 2 trials · 5 incl. sub-types Sub-types →
- Cholestasis, intrahepatic, of pregnancy, 1 0 trials
- Cholestasis, intrahepatic, of pregnancy, 3 0 trials
-
Disorder of lysosomal-related organelles 0 trials · 17 incl. sub-types
5 sub-types
-
Hypophosphatasia 13 trials
8 sub-types
- ALPL-related autosomal dominant hypophosphatasia 0 trials Sub-types →
- ALPL-related autosomal recessive hypophosphatasia 0 trials Sub-types →
- Adult hypophosphatasia 0 trials
- Childhood hypophosphatasia 0 trials
- Infantile hypophosphatasia 0 trials
- Moderate hypophosphatasia 0 trials
- Odontohypophosphatasia 0 trials
- Prenatal benign hypophosphatasia 0 trials
-
Familial hypoparathyroidism 0 trials · 10 incl. sub-types
3 sub-types
- Autosomal dominant hypocalcemia 9 trials · 10 incl. sub-types Sub-types →
- Hypoparathyroidism, familial isolated 1 0 trials Sub-types →
- Hypoparathyroidism, familial isolated, 2 0 trials
-
Inborn disorder of biogenic amine metabolism and transport 0 trials · 10 incl. sub-types
3 sub-types
- Inborn disorder of neurotransmitter metabolism and transport 0 trials · 4 incl. sub-types Sub-types →
- Inborn disorder of pyridoxine metabolism 0 trials · 4 incl. sub-types Sub-types →
- Metabolic disease involving other neurotransmitter deficiency 0 trials · 3 incl. sub-types Sub-types →
-
Neurodegeneration with brain iron accumulation 1 trial · 8 incl. sub-types
14 sub-types
- Neurodegeneration with brain iron accumulation 5 4 trials
- Pantothenate kinase-associated neurodegeneration 4 trials Sub-types →
- PLA2G6-associated neurodegeneration 1 trial Sub-types →
- Kufor-Rakeb syndrome 0 trials Sub-types →
- Woodhouse-Sakati syndrome 0 trials
- Aceruloplasminemia 0 trials
- Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Neurodegeneration with brain iron accumulation 4 0 trials
- Neurodegeneration with brain iron accumulation 6 0 trials
- Neurodegeneration with brain iron accumulation 7 0 trials
- Neurodegeneration with brain iron accumulation 8 0 trials
- Neurodegeneration with brain iron accumulation 9 0 trials
- Neuroferritinopathy 0 trials
-
Inherited thyroid metabolism disease 0 trials · 8 incl. sub-types
2 sub-types
- Familial thyroid dyshormonogenesis 1 trial · 4 incl. sub-types Sub-types →
- Thyroid hormone resistance syndrome 3 trials · 4 incl. sub-types Sub-types →
-
Inborn vitamin metabolic disorder 0 trials · 7 incl. sub-types
5 sub-types
- Disorders of vitamin D metabolism 0 trials · 3 incl. sub-types Sub-types →
- Inborn disorder of cobalamin metabolism and transport 1 trial · 3 incl. sub-types Sub-types →
- Cerebral folate deficiency 1 trial
- Familial isolated deficiency of vitamin E 1 trial
- Neurodegenerative syndrome due to cerebral folate transport deficiency 1 trial
-
Inborn aminoacylase deficiency 0 trials · 6 incl. sub-types
2 sub-types
- Canavan disease 6 trials Sub-types →
- Aminoacylase 1 deficiency 0 trials
-
Disorder of peptide and amine metabolism 0 trials · 4 incl. sub-types
4 sub-types
- Disorder of methylamine metabolism 0 trials · 2 incl. sub-types Sub-types →
- Disorder of polyamine metabolism 0 trials · 1 incl. sub-types Sub-types →
- Inherited glutathione metabolism disease 0 trials · 1 incl. sub-types Sub-types →
- Inborn disorder of peptide metabolism 0 trials Sub-types →
-
Diastrophic dysplasia 2 trials
-
Hypercalcemia, infantile 2 trials
2 sub-types
- Hypercalcemia, infantile, 1 0 trials
- Hypercalcemia, infantile, 2 0 trials
-
Hypoalphalipoproteinemia, primary, 1 2 trials
-
Congenital disorder of deglycosylation 0 trials · 2 incl. sub-types
2 sub-types
-
Fish eye disease 1 trial
-
2-hydroxyglutaric aciduria 0 trials · 1 incl. sub-types
3 sub-types
- D,L-2-hydroxyglutaric aciduria 1 trial
- D-2-hydroxyglutaric aciduria 0 trials Sub-types →
- L-2-hydroxyglutaric aciduria 0 trials
-
Familial hypocalciuric hypercalcemia 0 trials · 1 incl. sub-types
3 sub-types
-
Hereditary recurrent myoglobinuria 0 trials · 1 incl. sub-types
2 sub-types
-
Thiopurine metabolic disease 0 trials · 1 incl. sub-types
1 sub-type
-
4-hydroxyphenylacetic aciduria 0 trials
-
5-nucleotidase syndrome 0 trials
-
APO A-i deficiency 0 trials
-
3 sub-types
-
Lane Hamilton syndrome 0 trials
-
NAD(P)HX dehydratase deficiency 0 trials
-
3 sub-types
-
Achondrogenesis type IB 0 trials
-
Apolipoprotein c-III deficiency 0 trials
-
Aromatase excess syndrome 0 trials
-
Atelosteogenesis type II 0 trials
-
Autosomal dominant myoglobinuria 0 trials
-
Chondrocalcinosis 2 0 trials
-
Defective apolipoprotein b-100 0 trials
-
Ferro-cerebro-cutaneous syndrome 0 trials
-
Gluthathione peroxidase deficiency 0 trials
-
Hypercholesterolemia, familial, 4 0 trials
-
Hypermanganesemia with dystonia 0 trials
2 sub-types
-
Hypertriglyceridemia 1 0 trials
-
Hypertriglyceridemia 2 0 trials
-
Hypoalphalipoproteinemia, primary, 2 0 trials
1 sub-type
-
2 sub-types
-
Inborn glycerol kinase deficiency 0 trials
3 sub-types
-
Inherited threoninemia 0 trials
-
Multiple epiphyseal dysplasia type 4 0 trials
-
Striatonigral degeneration 0 trials
3 sub-types
-
Uridine-cytidineuria 0 trials
-
Weinstein kliman scully syndrome 0 trials
Most studied deeper sub-types
-
Can a One-Time gene therapy fix fabry disease for years?
Cure Stopped earlyThis study follows people with Fabry disease who have already received FLT190, an experimental gene therapy that delivers a working copy of the GLA gene. The goal is to see how safe the treatment is over the long term and whether its effects last. Researchers will track participa…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Can a single gene infusion rewrite the story of fabry disease?
Cure Stopped earlyThis trial is testing a gene therapy called FLT190 in adult men with classic Fabry disease, a genetic condition that causes harmful fat buildup in cells. The therapy uses a modified virus to deliver a working copy of the faulty gene, potentially enabling the body to produce the m…
Phase 1/2 • Sponsor: Spur Therapeutics • Aim: Cure
Last updated Sep 05, 2026 00:00 UTC
-
Double-Drug attack on Hard-to-Treat lymphomas
Disease control Stopped earlyResearchers are testing whether combining two chemotherapy drugs, pralatrexate and romidepsin, is safe and effective for people with lymphoid cancers that have returned or stopped responding to treatment. The trial first finds the highest dose people can tolerate, then gives that…
Phase 1/2 • Sponsor: Jennifer Amengual • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Slower magnesium drip may help sickest patients hold onto the mineral
Disease control Stopped earlyCritically ill patients often have low magnesium, which can lead to heart rhythm problems and other complications. When magnesium is given through an IV, the body keeps only about half of it. Researchers are testing whether giving the same dose over 8 hours instead of 4 hours hel…
Sponsor: CAMC Health System • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
Halted gene therapy study raises questions for AMN patients
Disease control Stopped earlyThis early-stage trial tested a gene therapy called SBT101 for adrenomyeloneuropathy (AMN), a rare nerve disease that causes walking difficulties. Eight adults received either the therapy or a sham procedure. The study was terminated early, so we have limited data on safety and e…
Phase 1/2 • Sponsor: SwanBio Therapeutics, Inc. • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Gene therapy aims to fix bone marrow failure in fanconi anemia
Disease control Stopped earlyThis trial tests a gene therapy for Fanconi anemia, a rare genetic disorder that causes bone marrow failure and increases cancer risk. Participants receive their own stem cells that have been genetically corrected with a lentiviral vector to fix the faulty FANCA gene. The study e…
Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can an inhaled protein save lungs in Alpha-1? new trial aims to find out
Disease control Stopped earlyThis study tests whether inhaling alpha-1 antitrypsin (AAT) daily can slow lung function loss in people with Alpha-1 deficiency and moderate-to-severe lung disease. 220 adults will receive either the drug or a placebo for two years, then all will receive the drug for two more yea…
Phase 3 • Sponsor: Kamada, Ltd. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
A common diabetes drug may protect against hormone therapy's metabolic side effects
Disease control Stopped earlyThis phase 3 trial tests whether metformin, a standard diabetes medication, can prevent or reverse metabolic syndrome in men with prostate cancer who are starting androgen deprivation therapy (ADT). Metabolic syndrome—a cluster of conditions like high blood sugar, high blood pres…
Phase 3 • Sponsor: Canadian Urologic Oncology Group • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Could a gel cut down on skin cancer surgeries? new trial investigates
Disease control Stopped earlyThis trial tests a gel called patidegib applied to the face twice daily for 9 months in people who develop many basal cell carcinomas (a common skin cancer) but do not have Gorlin syndrome. The goal is to see if the gel reduces the number of new skin cancers that would normally r…
Phase 2 • Sponsor: Sol-Gel Technologies, Ltd. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Experimental drug targets stubborn cholesterol in rare disease
Disease control Stopped earlyThis study tested an experimental drug called ARO-ANG3 in 18 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. Participants received injections of the drug and were monitored for safety and cholesterol change…
Phase 2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Promising seizure drug study halted early
Disease control Stopped earlyThis study looked at the long-term safety of the drug NBI-921352 for people with a rare genetic seizure disorder called SCN8A-DEE. It was an extension of an earlier study, and participants took the drug alongside their usual seizure medications. The study was stopped early and on…
Phase 2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Blood cancer transplant study tests safer GVHD prevention
Disease control Stopped earlyThis phase 2 trial tested two different drug combinations to prevent graft-versus-host disease (GVHD) in 150 people with blood cancers receiving a stem cell transplant from an unrelated donor. Both combinations used cyclosporine and sirolimus, plus either mycophenolate mofetil or…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Cancer drug combo trial halted early: what it means for patients
Disease control Stopped earlyThis study tested a combination of two drugs, ibrutinib and ixazomib, in 21 people with Waldenström macroglobulinemia, a rare blood cancer. The goal was to see if the combo could shrink or control the cancer. The trial was stopped early, so results are limited, but the approach a…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
MRNA therapy trial for rare acidemia halted early
Disease control Stopped earlyThis study tested an mRNA therapy called mRNA-3705 in 18 people with a rare genetic condition called methylmalonic acidemia, which causes harmful acid buildup. The therapy aimed to help the body produce a missing enzyme to lower acid levels. The trial was terminated early, so fin…
Phase 1/2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Experimental KRRO-110 trial for rare lung condition halted early
Disease control Stopped earlyThis study tested an experimental drug called KRRO-110 in healthy volunteers and people with Alpha-1 Antitrypsin Deficiency (AATD), a genetic condition that can cause lung and liver damage. The goal was to check safety and how the drug moves through the body. However, the trial w…
Phase 1/2 • Sponsor: Korro Bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could a common cholesterol drug protect bones and hearts after spinal injury?
Disease control Stopped earlyThis study tested whether the statin drug rosuvastatin, taken daily with supplements, could improve bone density and reduce heart disease risk in adults with long-term spinal cord injury. Only 8 people enrolled before the trial was stopped early. Participants received either rosu…
Phase 2 • Sponsor: Dr. B. Catharine. Craven • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Experimental drug for cholesterol and fatty liver fails to advance
Disease control Stopped earlyThis early-stage trial tested a new drug called LY3885125 in people with high cholesterol (dyslipidemia) and non-alcoholic fatty liver disease (NAFLD). The main goal was to check safety and how the body processes the drug. The study was terminated, meaning it stopped early, so it…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Promising liver drug trial halted early: what it means for patients
Disease control Stopped earlyThis study tested a new drug called belcesiran in people with a genetic condition called alpha-1 antitrypsin deficiency that causes liver damage. The goal was to see if the drug is safe and can lower harmful protein levels in the liver. The trial was stopped early, so results are…
Phase 2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Growth hormone study for short kids halted early
Disease control Stopped earlyThis study looked at two ways of giving growth hormone to short children who were born small for their age. The goal was to see which dosing method works better for growth and has fewer side effects on metabolism. Only 10 children took part before the study was stopped early.
Phase 4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug aims to tame hard-to-control seizures in rare mitochondrial disorders
Disease control Stopped earlyThis study tested a drug called vatiquinone in 68 people with mitochondrial disease and epilepsy that doesn't respond to standard treatments. Participants were randomly assigned to receive either vatiquinone or a placebo for 24 weeks to see if the drug could reduce the number of …
Phase 2/3 • Sponsor: PTC Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Plant-Based diet shows promise for diabetes remission in new study
Disease control Stopped earlyThis study looked at whether a plant-based diet and lifestyle changes could help people with type 2 diabetes, prediabetes, or obesity improve their health. Researchers aimed for diabetes remission (normal blood sugar without medication for at least 3 months) or significant weight…
Sponsor: National Council of Scientific and Technical Research, Argentina • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Obesity drug cocktail tested for heart benefits – study halted early
Disease control Stopped earlyThis study looked at whether using a combination of weight-loss medications could help people with obesity lose weight and improve the health of their blood vessels. It involved 128 adults aged 40-75 who were obese and had at least one heart risk factor. The study was stopped ear…
Phase 2 • Sponsor: University of Iowa • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New PKU formula shows promise in managing blood levels
Disease control Stopped earlyThis study tested a new amino acid formula called PKU GOLIKE in people aged 16 and older with phenylketonuria (PKU). The goal was to see if it could better control daily swings in blood phenylalanine levels compared to standard treatment. The study was stopped early, so results a…
Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Experimental CAR T-Cell therapy targets rare B-Cell cancers
Disease control Stopped earlyThis phase 2 study tested a treatment called brexucabtagene autoleucel, a CAR T-cell therapy made from a patient's own immune cells, for four rare B-cell cancers: Waldenstrom macroglobulinemia, Richter transformation, Burkitt lymphoma, and hairy cell leukemia. The trial enrolled …
Phase 2 • Sponsor: Kite, A Gilead Company • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Hope fades: trial of Tay-Sachs drug venglustat terminated early
Disease control Stopped earlyThis Phase 3 trial tested an oral drug called venglustat in 75 adults and children with late-onset Tay-Sachs or Sandhoff disease, rare genetic disorders that cause progressive nerve damage. The drug aimed to lower toxic fat buildup in the brain and slow disease worsening. However…
Phase 3 • Sponsor: Genzyme, a Sanofi Company • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental drug for rare lung disease shows early promise but trial halted
Disease control Stopped earlyThis early-phase study tested a drug called ARC-AAT in healthy volunteers and people with Alpha-1 Antitrypsin Deficiency (AATD), a genetic condition that can lead to lung and liver damage. The main goal was to check safety and how the drug affects levels of a key protein in the b…
Phase 1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for kids with rare hormone disorder: drug may cut steroid doses
Disease control Stopped earlyThis study tested an experimental drug called tildacerfont in 67 children aged 2 to 17 with congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The goal was to see if adding this once-daily pill to standard steroid treatment could improve d…
Phase 2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New dialysis device for Wilson's disease tested but trial stopped early
Disease control Stopped earlyThis trial tested a special dialysis device (MEX-CD1) designed to remove extra copper from the blood of people with Wilson's disease, a genetic condition that causes copper buildup. The study planned to give 5 to 10 treatments over consecutive days and check if the device worked …
Sponsor: Mexbrain • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Prostate cancer drug trialed to reduce steroids in kids with rare hormone disorder
Disease control Stopped earlyThis early-phase study tested a drug called abiraterone acetate (normally used for prostate cancer) in 4 children with congenital adrenal hyperplasia (CAH). The goal was to see if it could lower high male hormone levels and reduce the need for strong steroid medications that can …
Phase 1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Experimental cell therapy targets deadly childhood brain cancer
Disease control Stopped earlyThis early-phase trial tested a new immunotherapy approach for children with DIPG, a rare and aggressive brain stem tumor. After standard radiation and chemotherapy, patients received special vaccines and immune cells designed to attack the tumor. The study was small (11 particip…
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Promising epilepsy drug trial halted early – what we know
Disease control Stopped earlyThis study tested an experimental drug called NBI-921352 in people aged 2 to 21 with a rare, severe form of epilepsy caused by a change in the SCN8A gene. The goal was to see if adding this drug to their current seizure medicines could reduce how often they had seizures. The tria…
Phase 2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Experimental drug targets rare fat Disorder's metabolic woes
Disease control Stopped earlyThis phase 2 trial tested a drug called REGN4461 (mibavademab) in 20 people with familial partial lipodystrophy, a rare condition causing abnormal fat distribution and metabolic problems. The study aimed to see if the drug could lower high triglycerides and improve blood sugar co…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug aims to cut steroid use in rare hormone disorder
Disease control Stopped earlyThis study tested a daily tablet called Tildacerfont in 100 adults with classic congenital adrenal hyperplasia, a condition where the body can't make certain hormones properly. The goal was to see if the drug could safely reduce the high doses of steroids patients need to take. T…
Phase 2 • Sponsor: Spruce Biosciences • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Heart risk check for schizophrenia drugs
Disease control Stopped earlyThis study aimed to see how two antipsychotic drugs, aripiprazole and ziprasidone, affect heart risk in people with schizophrenia, schizoaffective disorder, or bipolar disorder. Researchers measured blood fats and heart electrical changes in 48 adults over 12 months. The trial wa…
Phase 3 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Could a diabetes drug help kids with rare PMM2-CDG?
Disease control Stopped earlyThis study tested an oral drug called epalrestat, originally used for diabetic nerve pain, in children with PMM2-CDG, a rare genetic disorder that causes nerve problems and other symptoms. The trial aimed to see if the drug could safely improve nerve function and metabolic marker…
Phase 3 • Sponsor: Maggie's Pearl, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Heart drug for diabetics shows promise but trial ends early
Disease control Stopped earlyThis study tested whether pemafibrate, a drug that lowers triglycerides, could reduce heart attacks, strokes, and heart-related deaths in over 10,000 people with type 2 diabetes and high triglycerides. Participants took either pemafibrate or a placebo twice daily. The trial was t…
Phase 3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Experimental therapy for rare metabolic disease shows early promise
Disease control Stopped earlyThis study tested a new medicine called ARCT-810 in 8 people aged 12 to 65 with ornithine transcarbamylase (OTC) deficiency, a rare genetic disorder that causes dangerous ammonia buildup. The main goal was to check the drug's safety and how the body processes it. The trial was st…
Phase 2 • Sponsor: Arcturus Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Experimental drug zavesca tested for rare fatal brain diseases in infants
Disease control Stopped earlyThis phase 3 trial tested the drug miglustat (Zavesca) in 30 infants with Sandhoff or Tay-Sachs diseases, rare genetic disorders that destroy nerve cells. The goal was to see if the drug could reduce hospitalizations, seizures, and feeding problems while improving motor function.…
Phase 3 • Sponsor: Tehran University of Medical Sciences • Aim: Disease control
Last updated Jun 26, 2026 17:51 UTC
-
Pompe disease drug trial halted after just 3 patients
Disease control Stopped earlyThis study tested an oral drug called duvoglustat in adults with Pompe disease, a rare genetic disorder that causes muscle weakness. Only 3 people took part, and the study was stopped early. Researchers looked at safety and whether the drug could improve walking distance and othe…
Phase 2 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 16:43 UTC
-
Experimental pill for rare lung and liver disease hits snag: trial stopped early
Disease control Stopped earlyThis study tested an experimental drug called VX-864 in 14 people with a severe form of alpha-1 antitrypsin deficiency (PiZZ genotype). The goal was to see if the pill could raise protective protein levels in the blood and reduce harmful buildup in the liver. The trial was termin…
Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Jun 26, 2026 15:04 UTC
-
Experimental drug pomalidomide tested in rare blood cancer
Disease control Stopped earlyThis early-phase trial tested the drug pomalidomide in 15 people with Waldenstrom macroglobulinemia, a rare blood cancer that had returned or was not responding to prior treatments. The goal was to find the safest dose and see how the drug affects the immune system and cancer gro…
Phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 14:07 UTC
-
Experimental gene therapy targets Tay-Sachs and sandhoff in kids
Disease control Stopped earlyThis early-stage trial tested a gene therapy called AXO-AAV-GM2 in children with Tay-Sachs or Sandhoff disease, rare and fatal genetic brain disorders. The therapy delivers healthy genes directly into the brain and spinal fluid to try to restore a missing enzyme. The study was te…
Phase 1 • Sponsor: Terence Flotte • Aim: Disease control
Last updated Jun 26, 2026 13:03 UTC
-
Porphyria prevention study halted early – little data to go on
Prevention Stopped earlyThis small phase 2 trial tested whether the drug Panhematin could prevent acute attacks in people with certain types of porphyria. Only 13 participants were enrolled before the study was terminated early. Researchers tracked attacks and serious side effects, but the limited data …
Phase 2 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
Can a scented fan ease breathlessness at the end of life?
Symptom relief Stopped earlyThis study looked at whether blowing a fan with aromatherapy on the face can help reduce breathlessness in people with terminal illness. The trial planned to enroll 26 adults who were near the end of life and had trouble breathing. Participants were randomly assigned to receive a…
Sponsor: Tsai-Wei Huang • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Can an antioxidant supplement ease bladder troubles in older women?
Symptom relief Stopped earlyThis pilot study tested whether MitoQ, an antioxidant supplement, could improve bladder symptoms like urgency and frequency in women aged 50 and older with metabolic syndrome. Twenty participants took either MitoQ or a placebo for 4 months, tracking their symptoms through questio…
Phase 2 • Sponsor: Iman Al-Naggar, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Home infusions may help patients stick to treatment
Knowledge-focused Stopped earlyThis study looks at whether people with Fabry, Gaucher, or Hunter disease are more likely to continue their IV treatment when it's given at home versus at a hospital. Researchers will review existing data from 222 patients in Mexico. No new treatments are given; the goal is to un…
Sponsor: Takeda • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC
-
20-Year review of lymphoma care reveals Real-World treatment success
Knowledge-focused Stopped earlyThis study examines the medical records of 400 people diagnosed with various types of lymphoma at a French hospital between 1999 and 2018. Researchers want to see how long patients survived and whether the care they received matched what medical guidelines recommend. The goal is …
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Gene Editing's lasting impact: a 10-Year safety watch
Knowledge-focused Stopped earlyThis study checks on people who previously received gene editing for hemophilia B or mucopolysaccharidosis (MPS) I or II. No new treatment is given; instead, participants are monitored for up to 10 years to see if any new health problems or worsening of existing conditions appear…
Sponsor: Sangamo Therapeutics • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Scientists dive into rare cholesterol disorders to uncover clues
Knowledge-focused Stopped earlyThis study looks at rare genetic disorders where the body can't make cholesterol properly, which can cause birth defects and learning problems. Researchers collect blood, urine, and tissue samples from affected people and their families to learn more about these conditions. The g…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
MRI might reveal hidden pancreatic risks in obesity
Knowledge-focused Stopped earlyThis study investigates whether MRI can detect early signs of pancreatic damage linked to obesity and metabolic syndrome, which are risk factors for pancreatic cancer. Researchers will compare MRI images with tissue samples from patients undergoing pancreatic surgery, as well as …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Russian study seeks hidden cases of rare liver disease in kids
Knowledge-focused Stopped earlyThis study looks at children and teens in Russia who may have a rare genetic condition called lysosomal acid lipase deficiency (LAL-D). Researchers will check for the disease in up to 1,200 participants using blood tests and genetic testing. The goal is to understand how often LA…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Tafamidis tablet vs capsule: which works better?
Knowledge-focused Stopped earlyThis early-stage study aimed to compare how a tablet form of tafamidis is absorbed in the body compared to the existing capsule form. It involved 24 healthy adults who took a single dose of each form under fed conditions. The study was terminated early, so results may be limited.
Phase 1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
Fabry disease sperm study halted early
Knowledge-focused Stopped earlyThis study aimed to find out how common sperm problems are in men with Fabry disease. Researchers planned to check sperm samples from 22 men aged 18 to 65. The study was stopped early, so results are limited.
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
PKU diet in childhood may shape adult IQ, study finds
Knowledge-focused Stopped earlyThis study looks at adults with phenylketonuria (PKU) who were diagnosed as newborns and treated with a special diet. Researchers want to see if how long and how strictly they followed the diet as children affects their intelligence (IQ) as adults. The goal is to use this informa…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Why are people with this rare bone disorder prone to diabetes?
Knowledge-focused Stopped earlyThis pilot study aims to understand why people with pseudohypoparathyroidism type 1A (PHP1A) have a higher risk of type 2 diabetes. Researchers will measure insulin sensitivity and beta-cell function in 14 participants with PHP1A or related conditions, comparing them to matched h…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Superhero training for food allergy safety falls short
Knowledge-focused Stopped earlyThis study aimed to help children aged 6-8 from low-income families learn how to avoid foods they are allergic to. The program used fun, hands-on activities to teach safety skills. The study was stopped early, so we don't have clear results on whether it worked.
Sponsor: Kent State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Ibrutinib heart risks under the microscope: can we predict them?
Knowledge-focused Stopped earlyThis study aimed to understand why some people taking the cancer drug ibrutinib develop heart issues like atrial fibrillation (irregular heartbeat) and high blood pressure. Researchers planned to follow 8 patients with blood cancers, using heart tests and blood markers to try to …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Heart study explores Yoga's effect on genes
Knowledge-focused Stopped earlyThis study tested whether a 16-week program of yoga and lifestyle changes could affect gene activity (micro RNA) and heart disease risk factors in 16 adults with coronary artery disease. Participants had either undergone a heart procedure or had non-obstructive heart disease with…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Rare disease study aims to map MLIV's natural course
Knowledge-focused Stopped earlyThis study followed 7 people with Mucolipidosis Type IV (MLIV) to learn how the disease naturally progresses. Researchers used tests like neuropsychological exams, blood and urine tests, and brain MRIs to find better ways to measure the disease. The goal was to improve future cli…
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:14 UTC
-
Rare disease mystery: scientists watch AMN progress in hopes of finding a cure
Knowledge-focused Stopped earlyThis study followed 65 adult men with a rare inherited nerve disease called AMN (a form of spastic paraplegia) to understand how their symptoms change over time. Researchers collected data on walking ability and quality of life. The goal was to fill gaps in knowledge about the di…
Sponsor: SwanBio Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Hidden heart condition: study seeks to uncover missed diagnosis in heart failure patients
Knowledge-focused Stopped earlyThis study aims to find out how common transthyretin amyloidosis cardiomyopathy (ATTR-CM) is in Russian patients with a certain type of heart failure. Researchers will review medical records and then invite some patients for extra heart tests to confirm or rule out ATTR-CM. The g…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:47 UTC
-
Gene therapy for krabbe disease: did it last?
Knowledge-focused Stopped earlyThis study follows up on children with Krabbe disease who received a one-time gene therapy infusion (FBX-101) in earlier trials. Researchers will monitor safety and measure motor skills over time. Only 2 participants are enrolled, so results are very limited.
Sponsor: Forge Biologics, Inc • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:47 UTC